Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | GABRP | O00591 | 2/20 | 0.56 |
| ▸ | GABRD | O14764 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.56 |
| ▸ | GABRE | P78334 | 2/20 | 0.56 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.56 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.56 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.56 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.56 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.56 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.52 |
| ▸ | KDM4A | O75164 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28750 | 1.00 | CYP1A2 (1.00) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL7321898 | 1.00 | CYP1A2 (1.00) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL6737627 | 0.97 | CYP1A2 (0.95) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL10882526 | 0.97 | CYP1A2 (0.95) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| Methane SCHEMBL28098974 | 0.97 | CYP1A2 (0.95) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL10883495 | 0.97 | CYP1A2 (0.95) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| Ammonia Solution, Strong SCHEMBL1023860 | 0.97 | CYP1A2 (0.95) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| Water SCHEMBL14109081 | 0.95 | CYP1A2 (0.90) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| Alcohol SCHEMBL6917476 | 0.93 | CYP1A2 (0.86) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL22283560 | 0.93 | CYP1A2 (0.86) | CYP1A2GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120188854-A | Nutritional feed based on urea and application of nutritional feed in ruminants | 云南牛牛牧业股份有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-115770225-B | Cardiglutamic acid freeze-dried solid preparation and preparation method thereof | 远大医药（中国）有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-116947704-A | Bulk drug of kaglutamic acid and preparation method thereof | 武汉武药科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116808013-A | Bulk pharmaceutical chemical of carglutamic acid, solid preparation of carglutamic acid and preparation method thereof | 武汉武药科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-114522147-B | Solid preparation of carboglutamic acid and preparation method thereof | 武汉武药科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-112028794-B | High-purity carboglutamic acid and preparation method thereof | 武汉武药科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-120188854-A | Nutritional feed based on urea and application of nutritional feed in ruminants | 云南牛牛牧业股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120188854-A | Nutritional feed based on urea and application of nutritional feed in ruminants | 云南牛牛牧业股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-115770225-B | Cardiglutamic acid freeze-dried solid preparation and preparation method thereof | 远大医药（中国）有限公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-115770225-B | Cardiglutamic acid freeze-dried solid preparation and preparation method thereof | 远大医药（中国）有限公司 | 2024-09-17 | — | — | CN | disclosed |
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
| US-20230346752-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2023-11-02 | — | — | US | disclosed |
| US-20230346752-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2023-11-02 | — | — | US | disclosed |
| US-7439258-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD (CA) | 2008-10-21 | — | — | US | disclosed |
| US-7439258-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD (CA) | 2008-10-21 | — | — | US | disclosed |
| WO-2008036247-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2008-03-27 | — | — | WO | disclosed |
| US-7312188-B2 | Peptide derivatives having β-secretase inhibitory activity | KISO YOSHIAKI | 2007-12-25 | — | — | US | disclosed |
| US-20070004637-A1 | Peptide derivatives having beta-secretase inhibitory activity | KISO YOSHIAKI | 2007-01-04 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | CYP1A2 4237/4885GABRP 206/4885GABRD 573/4885 |
| US-20070004637-A1 | Peptide derivatives having beta-secretase inhibitory activity | BACE1, BACE2, APP | CYP1A2 1983/4885GABRP 215/4885GABRD 398/4885 |
| US-20230346752-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | CYP1A2 4799/4885GABRP 449/4885GABRD 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.